SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-22-015611
Filing Date
2022-06-29
Accepted
2022-06-28 18:00:19
Documents
84
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F form20f.htm   iXBRL 20-F 1784490
2 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 5844
3 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 5887
4 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 3796
5 EXHIBIT 13.2 exhibit13-2.htm EX-13.2 3763
11 GRAPHIC form20fxz001.jpg GRAPHIC 3142
  Complete submission text file 0001062993-22-015611.txt   8146850

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repcf-20211231.xsd EX-101.SCH 138393
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repcf-20211231_cal.xml EX-101.CAL 31213
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repcf-20211231_def.xml EX-101.DEF 242807
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT repcf-20211231_lab.xml EX-101.LAB 1056746
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repcf-20211231_pre.xml EX-101.PRE 400545
78 EXTRACTED XBRL INSTANCE DOCUMENT form20f_htm.xml XML 1230315
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-50112 | Film No.: 221051282
SIC: 2836 Biological Products, (No Diagnostic Substances)